SYRS

Syros Pharmaceuticals, Inc. Common Stock
SYRS

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SYRS was delisted on the 19th of March, 2025.

Back to rankings

12 hedge funds and large institutions have $207M invested in Syros Pharmaceuticals, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 12 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$38M
2
+$37.8M
3
+$16.5M
4
RG
Redmile Group
California
+$15.1M
5
BBA
Baker Bros. Advisors
New York
+$3.71M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$87.2M
2
$38M
3
$37.8M
4
$16.5M
5
$15.1M
6
$3.71M
7
$2.72M
8
$2.72M
9
$1.27M
10
$908K
11
$832K
12
$363K